Genetic Modifiers of Alzheimer Risk Administrative Supplement We have identified a blood biomarker signal that differentiates genetically mutant Alzheimer disease (AD)-model mice from their age- and sex-matched non-mutant littermates: markers of the cellular response to DNA damage. This supplement to the KOMP project will define the detection limits of the assay signal in time, pre-disease, and breadth of models detectable, and will examine viable knock-out mice generated in the KOMP project for signal in the blood assay as a simple screen for knock-outs with AD and pre-AD properties. This work has the potential to identify new AD risk alleles, and to produce a simple, early initial blood-based biomarker and assay for AD risk. Simple blood screens for pre-AD phenotypes could allow identification and potentially prevention of symptoms in at-risk individuals not otherwise identified.
The purpose of this supplement to the Baylor College of Medicine Knock-Out Mouse Production and Phenotyping project (KOMP2) is to develop a promising blood-based assay for early detection of Alzheimer disease (AD) in the pre-clinical mouse model, and to screen knock-out mice generated by the KOMP2 for knock outs that predispose to AD. This work may advance early detection and prevention of AD.
Showing the most recent 10 out of 20 publications